Back to mobile site

Wells Fargo Starts NuVasive (NUVA) at Market Perform; Facing Market and Competitive Headwinds

April 9, 2012 7:45 AM EDT
Get Alerts NUVA Hot Sheet
Price: $39.75 --0%

Rating Summary:
    11 Buy, 21 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wells Fargo initiates coverage on NuVasive (NASDAQ: NUVA) with a Market Perform. PT range $16-17.

Wells analyst said, "NUVA is the number 5 player in the global spine market. Although NUVA’s top-line growth has outpaced the overall spine market since the company went public in 2004, our rating is based on our belief that: (1) the US spine market (92% of total NUVA sales) will remain under pressure through 2012; (2) physician owned distributors (PODs) will continue to take share from larger players such as NUVA; (3) NUVA will face increasing competition in its core lateral fusion business; (4) NUVA’s margins will decline through 2013; and (5) NUVA’s cash position will constrain its ability to pursue business development activities."

For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.

Shares of NuVasive closed at $15.88 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Wells Fargo